Local anesthetics and immunotherapy: a novel combination to fight cancer
Seminars in Immunopathology · 2023-03 · 45 (2) · 265-272
DOI: 10.1007/s00281-022-00960-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, online erschienen am 31.08.2022. Verfasst von Lucillia Bezu und 2 weiteren Autor:innen. Beteiligte Einrichtung: UMR1138, Centre de Recherche Des Cordeliers, Equipe Labellisée Par La Ligue Contre Le Cancer, Université de Paris, Sorbonne Université, INSERM, Insti…. Hauptthemen laut MEDLINE: Oncolytic Virotherapy, Oncolytic Viruses, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Abstract (Originalsprache)
Intratumoral injection of oncolytic agents such as modified herpes simplex virus T-VEC or local administration of non-viral oncolytic therapies (such as radiofrequency, chemoembolization, cryoablation, or radiotherapy) can activate an anticancer immune response and hence trigger abscopal effects reducing secondary lesions. Preliminary data suggested that oncolytic treatments modulate tumor-infiltrating immune effectors and can be advantageously combined with the immune checkpoint inhibitors. Recent findings indicate that local anesthetics, which are usually used in the clinics to control surgical pain, also possess antineoplastic effects mimicking oncolytic treatments if they are injected into malignant lesions. Moreover, the association of local anesthetics with systemic immune checkpoint inhibition significantly improved overall survival in several preclinical tumor models. This may be explained by direct cytotoxic activity of local anesthetics and additional immune-related abscopal effects. We also summarize the molecular and cellular mechanisms by which the combination of local anesthetics and immunotherapy improves tumor control by the immune system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UMR1138, Centre de Recherche Des Cordeliers, Equipe Labellisée Par La Ligue Contre Le Cancer, Université de Paris, Sorbonne Université, INSERM, Institut Universitaire de France, Paris, France. lucilliabe@gmail.com.
- Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France. lucilliabe@gmail.com.
- Service d'Anesthésie Gustave Roussy Cancer Campus, Villejuif, France. lucilliabe@gmail.com.
- EuroPeriscope: Onco-Anaesthesiology Research Group, Brussels, Belgium. lucilliabe@gmail.com.
- UMR1138, Centre de Recherche Des Cordeliers, Equipe Labellisée Par La Ligue Contre Le Cancer, Université de Paris, Sorbonne Université, INSERM, Institut Universitaire de France, Paris, France.
- Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.
Zitieren
APA
Bezu, L., Kepp, O., & Kroemer, G. (2023). Local anesthetics and immunotherapy: a novel combination to fight cancer. Seminars in Immunopathology, 45(2), 265-272. https://doi.org/10.1007/s00281-022-00960-6
Vancouver
Bezu L, Kepp O, Kroemer G. Local anesthetics and immunotherapy: a novel combination to fight cancer. Seminars in Immunopathology. 2023;45(2):265-272. doi:10.1007/s00281-022-00960-6
BibTeX
@article{Bezu2023,
author = {Bezu, Lucillia and Kepp, Oliver and Kroemer, Guido},
title = {Local anesthetics and immunotherapy: a novel combination to fight cancer},
journal = {Seminars in Immunopathology},
year = {2023},
volume = {45},
number = {2},
pages = {265--272},
doi = {10.1007/s00281-022-00960-6}
}
EUVIMED